CO89 Integrated Analysis of Efficacy and ICU Length of Stay Data From Phase 2 and Phase 3 Trials of Rezafungin for the Treatment of Invasive Candidiasis and/or Candidemia
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.168
https://www.valueinhealthjournal.com/article/S1098-3015(22)02372-5/fulltext
Title :
CO89 Integrated Analysis of Efficacy and ICU Length of Stay Data From Phase 2 and Phase 3 Trials of Rezafungin for the Treatment of Invasive Candidiasis and/or Candidemia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02372-5&doi=10.1016/j.jval.2022.09.168
First page :
Section Title :
Open access? :
No
Section Order :
11284